{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:41:07Z","timestamp":1740807667233,"version":"3.38.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.remnie.2025.500083","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T17:35:35Z","timestamp":1737567335000},"page":"500083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\"Utility of PET\/CT with [18F] F-fluorocholine in assessing the response to antiandrogenic therapy in patients with prostate cancer.\""],"prefix":"10.1016","volume":"44","author":[{"given":"K.","family":"Quintero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferrer-Mileo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garcia-Herreros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tormo-Ratera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Farr\u00e9-Melero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.remnie.2025.500083_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1016\/j.remnie.2025.500083_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.juro.2007.08.133","article-title":"The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy","volume":"179","author":"Makarov","year":"2008","journal-title":"J Urol."},{"issue":"4","key":"10.1016\/j.remnie.2025.500083_bib0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer\u2013specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.remnie.2025.500083_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2021.06.010","article-title":"The treatment landscape of metastatic prostate cancer","volume":"519","author":"Yamada","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.remnie.2025.500083_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00259-015-3177-4","article-title":"11C-Choline PET\/CT in castration-resistant prostate cancer patients treated with docetaxel","volume":"43","author":"Ceci","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging [Internet]"},{"issue":"8","key":"10.1016\/j.remnie.2025.500083_bib0030","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/j.ejrad.2012.04.027","article-title":"Role of 11C-choline PET\/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy","volume":"81","author":"Fuccio","year":"2012","journal-title":"Eur J Radiol."},{"issue":"23","key":"10.1016\/j.remnie.2025.500083_bib0035","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.18632\/oncotarget.2558","article-title":"Early outcome prediction on 18F-fluorocholine PET\/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone","volume":"5","author":"De Giorgi","year":"2014","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.remnie.2025.500083_bib0040","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00259-015-3042-5","article-title":"18F-Fluorocholine PET\/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide","volume":"42","author":"De Giorgi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"10.1016\/j.remnie.2025.500083_bib0045","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222148","article-title":"Response evaluation criteria in PSMA PET\/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer","volume":"308","author":"Gafita","year":"2023","journal-title":"Radiology."},{"issue":"5","key":"10.1016\/j.remnie.2025.500083_bib0050","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2967\/jnumed.119.233817","article-title":"Proposal for systemic-therapy response-assessment criteria at the time of PSMA PET\/CT imaging: the PSMA PET progression criteria","volume":"61","author":"Fanti","year":"2020","journal-title":"J Nucl Med."},{"issue":"5","key":"10.1016\/j.remnie.2025.500083_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"issue":"4","key":"10.1016\/j.remnie.2025.500083_bib0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol."},{"issue":"9","key":"10.1016\/j.remnie.2025.500083_bib0065","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1470-2045(08)70203-1","article-title":"MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study","volume":"9","author":"Heesakkers","year":"2008","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.remnie.2025.500083_bib0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0969-8051(00)00195-5","article-title":"Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells","volume":"28","author":"Yoshimoto","year":"2001","journal-title":"Nucl Med Biol."},{"issue":"7","key":"10.1016\/j.remnie.2025.500083_bib0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3109\/0284186X.2013.865078","article-title":"What is the role of [11C]choline PET\/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients?","volume":"53","author":"Alongi","year":"2014","journal-title":"Acta Oncol (Madr)."},{"issue":"9","key":"10.1016\/j.remnie.2025.500083_bib0080","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2967\/jnumed.114.138313","article-title":"Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11 C-Choline PET\/CT scan before salvage radiation therapy?","volume":"55","author":"Castellucci","year":"2014","journal-title":"J Nucl Med."},{"issue":"2","key":"10.1016\/j.remnie.2025.500083_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2967\/jnumed.113.123380","article-title":"11C-Choline PET\/CT predicts prostate cancer\u2013specific survival in patients with biochemical failure during androgen-deprivation therapy","volume":"55","author":"Giovacchini","year":"2014","journal-title":"J Nucl. Med."},{"issue":"1","key":"10.1016\/j.remnie.2025.500083_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","article-title":"The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Umbehr","year":"2013","journal-title":"Eur Urol."},{"issue":"7","key":"10.1016\/j.remnie.2025.500083_bib0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162907","article-title":"Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer","volume":"8","author":"Sayar","year":"2023","journal-title":"JCI Insight."},{"issue":"2","key":"10.1016\/j.remnie.2025.500083_bib0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/ERC-18-0226","article-title":"Neuroendocrine differentiation of prostate cancer leads to PSMA suppression","volume":"26","author":"Bakht","year":"2019","journal-title":"Endocr Relat Cancer."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:28:02Z","timestamp":1740760082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2253808925000114"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500083","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"Utility of PET\/CT with [18F] F-fluorocholine in assessing the response to antiandrogenic therapy in patients with prostate cancer.\"","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500083"}}